New Zealand markets close in 17 minutes

SunWay Biotech Co., LTD. (1271.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
107.50+2.00 (+1.91%)
As of 12:16PM CST. Market open.
Currency in TWD

Valuation measures4

Market cap (intra-day) 6.15B
Enterprise value 6.09B
Trailing P/E 70.41
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.43
Price/book (mrq)1.92
Enterprise value/revenue 10.66
Enterprise value/EBITDA 72.94

Trading information

Stock price history

Beta (5Y monthly) -0.06
52-week change 3110.37%
S&P500 52-week change 324.52%
52-week high 3145.50
52-week low 348.35
50-day moving average 3116.28
200-day moving average 3104.58

Share statistics

Avg vol (3-month) 3139.69k
Avg vol (10-day) 3109.23k
Shares outstanding 559.39M
Implied shares outstanding 660.71M
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 40.97%
Trailing annual dividend rate 31.00
Trailing annual dividend yield 30.95%
5-year average dividend yield 4N/A
Payout ratio 4217.78%
Dividend date 3N/A
Ex-dividend date 411 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 7.72%
Operating margin (ttm)-0.52%

Management effectiveness

Return on assets (ttm)1.52%
Return on equity (ttm)2.55%

Income statement

Revenue (ttm)571.11M
Revenue per share (ttm)19.09
Quarterly revenue growth (yoy)69.80%
Gross profit (ttm)N/A
EBITDA 64.02M
Net income avi to common (ttm)44.08M
Diluted EPS (ttm)1.47
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)362.19M
Total cash per share (mrq)6.1
Total debt (mrq)287.35M
Total debt/equity (mrq)8.98%
Current ratio (mrq)3.99
Book value per share (mrq)53.84

Cash flow statement

Operating cash flow (ttm)55.98M
Levered free cash flow (ttm)-76.39M